Inactive Instrument

Press Releases American Biogenetic Sciences, Inc. Other OTC

Equities

US0246113031

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-13	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-27	QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QHSLab, Inc. Announces Strong First Quarter 2024 Results with Significant Reduction in Operating Expenses and Positive Net Operating Income	05-13	AQ
QHSLab, Inc. Enhances Leadership Team with Dr. Marcos Sanchez-Gonzalez as New VP of Medical and Scientific Affairs	05-02	AQ
QHSLab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results	04-26	AQ
QHSLab Announces Impressive 2023 Fiscal Year Results with Growing Revenues, Improved Gross Margins, and Substantial Reduction in Net Loss	03-28	AQ
QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company	01-30	AQ
QHSLab, Inc. (USAQ) Reports Third Quarter Financial Results	11-14	AQ
QHSLab Welcomes Six New Integrated Service Program (ISP) Customer Accounts and Launches Enhanced Website for Improved Customer Engagement	23-10-25	AQ
QHSLab Continues to Lead the Way in Digital Healthcare with Impressive Year-to-Date Achievements in Patient-Centric Innovations and Advancements in Behavioral Healthcare	23-10-18	AQ
QHSLab, Inc. Reports First Quarter Financial Results	23-05-15	AQ
QHSLAB, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-29	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-02-16	AQ
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology Specialists of Florida	23-02-16	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-01-30	AQ
QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care	23-01-30	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-11-14	AQ
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care	22-11-14	GL
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care	22-11-14	AQ
QHSLAB, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	22-11-14	AQ
QHSLAB, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-11-01	AQ
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force	22-11-01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases American Biogenetic Sciences, Inc. Other OTC

Equities

US0246113031

Press Releases

Filters